OpenAI CEO Sam Altman expects advances in AI-powered scientific research to help identify potential treatments for serious diseases within the next couple of years. In an interview with podcaster Matthew Berman, he discussed the technology’s promise for drug discovery, and the challenges of making scientific progress useful to society.
firstpost.com
firstpost.com
